Dorothea Matysiak-Klose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dorothea Matysiak-Klose has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Annette Mankertz
2 shared publications- Ole Wichmann
Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
2 shared publications - Alex Sánchez-Vivar
Health Protection Scotland (HPS) and the Scottish Health Protection Network (HPN), Glasgow, UK
1 shared publication Andrea Kühne
1 shared publication- Andreas Jansen
European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
1 shared publication - Anette Siedler
Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Berlin, Germany
1 shared publication
Latest Publications
- 30 May 2025
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 122 (11) , m1038-m1039
Letters to the Editor
- 30 May 2025
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 122 (11) , m1038-m1039
Letters to the Editor
- 27 December 2024
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 121 (Forthcomin) , 875-881
The epidemiology and diagnosis of measles—special aspects relating to low incidence
Measles is a highly contagious viral disease (contagion index near 100%) with a complication rate of up to 30%. The worldwide incidence for 2022 was calculated as 29 cases per million people. Measles can be eliminated if 95% of the population is either vaccinated or immune and measures are taken to limit its spread as soon as an initial suspected case is encountered. However, the worldwide immunization rate has fallen since 2020 (from 86% in 2019 to 81% in 2021). To assess the epidemiological situation and describe the state of scientific knowledge regarding laboratory tests for measles, we analyzed recent epidemiological data from the Robert-Koch Institute (RKI) and reviewed pertinent publications retrieved by a selective literature search. Repeated importations of measles virus have led to a new rise in case numbers in Germany since last year. 79 cases of measles were reported to the RKI in 2023, and 475 in the first eight months of 2024. The latter figure corresponds to the pre-pandemic level. There are still immunization gaps in the population: for instance, by the age of 24 months, 93.7% of children have received their first immunization, and only 80.5% have received the second. Every suspected case must be confirmed by laboratory testing so that targeted measures can be initiated. Serology is no longer considered sufficiently reliable; a reliable diagnosis now requires a polymerase chain reaction (PCR) test. The specimen can be a throat swab or a urine sample. PCR also enables the differentiation of measles virus variants and the tracing of transmission chains. Reliable laboratory testing makes it possible to detect measles cases rapidly, initiate measures to slow the spread of the disease, trace infection chains, and assess the risk exposure for measles in Germany.
- 27 December 2024
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 121 (Forthcomin) , 875-881
The epidemiology and diagnosis of measles—special aspects relating to low incidence
Measles is a highly contagious viral disease (contagion index near 100%) with a complication rate of up to 30%. The worldwide incidence for 2022 was calculated as 29 cases per million people. Measles can be eliminated if 95% of the population is either vaccinated or immune and measures are taken to limit its spread as soon as an initial suspected case is encountered. However, the worldwide immunization rate has fallen since 2020 (from 86% in 2019 to 81% in 2021). To assess the epidemiological situation and describe the state of scientific knowledge regarding laboratory tests for measles, we analyzed recent epidemiological data from the Robert-Koch Institute (RKI) and reviewed pertinent publications retrieved by a selective literature search. Repeated importations of measles virus have led to a new rise in case numbers in Germany since last year. 79 cases of measles were reported to the RKI in 2023, and 475 in the first eight months of 2024. The latter figure corresponds to the pre-pandemic level. There are still immunization gaps in the population: for instance, by the age of 24 months, 93.7% of children have received their first immunization, and only 80.5% have received the second. Every suspected case must be confirmed by laboratory testing so that targeted measures can be initiated. Serology is no longer considered sufficiently reliable; a reliable diagnosis now requires a polymerase chain reaction (PCR) test. The specimen can be a throat swab or a urine sample. PCR also enables the differentiation of measles virus variants and the tracing of transmission chains. Reliable laboratory testing makes it possible to detect measles cases rapidly, initiate measures to slow the spread of the disease, trace infection chains, and assess the risk exposure for measles in Germany.
- Open Access
- 1 August 2021
- Published by Elsevier in Vaccine: X
- Vol. 8, 100094
Cancelled routine vaccination appointments due to COVID-19 pandemic in Germany
- 1 August 2021
- Published by Elsevier in Vaccine: X
- Vol. 8, 100094
Open AccessCancelled routine vaccination appointments due to COVID-19 pandemic in Germany
- 16 November 2017
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 142 (23) , 1767-1772
Masern in Deutschland – Epidemiologie und Management
Measles are one of the most contagious diseases of mankind. Measles incidence has declined worldwide since the introduction of vaccinations. Due to low numbers of measles cases in countries with high vaccination rates the population is not aware of possible complications of measles any more. Measles elimination is an important goal set by all regions of the World Health Organization. However, it remains a challenge for Germany and other European countries. Because of a high proportion of susceptibles in specific population and age groups outbreaks take place in Germany every year after importation of the virus. More than 50 % of measles cases are 20 years and older. However, the highest incidences have been seen in two-year-olds since several years. In addition to epidemiological findings such as case numbers and risk groups, genotyping permits e. g. an assessment of the endemic circulation of viruses. Suspicion of a measles case should result in immediate and consistent measures. Die Masern sind eine der ansteckendsten Erkrankungen der Menschheit. Trotz weltweit gesunkener Inzidenz kommt es weiterhin zu Masernausbrüchen mit z. T. hohen Fallzahlen. Epidemiologische Erkenntnisse und die molekulare Surveillance durch Genotypisierung von Masernviren liefern wichtige Hinweise bzgl. der endemischen Verbreitung der Viren. Bereits bei Verdacht auf einen Masernfall sollten sofort Maßnahmen eingeleitet werden.
- 16 November 2017
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 142 (23) , 1767-1772
Masern in Deutschland – Epidemiologie und Management
Measles are one of the most contagious diseases of mankind. Measles incidence has declined worldwide since the introduction of vaccinations. Due to low numbers of measles cases in countries with high vaccination rates the population is not aware of possible complications of measles any more. Measles elimination is an important goal set by all regions of the World Health Organization. However, it remains a challenge for Germany and other European countries. Because of a high proportion of susceptibles in specific population and age groups outbreaks take place in Germany every year after importation of the virus. More than 50 % of measles cases are 20 years and older. However, the highest incidences have been seen in two-year-olds since several years. In addition to epidemiological findings such as case numbers and risk groups, genotyping permits e. g. an assessment of the endemic circulation of viruses. Suspicion of a measles case should result in immediate and consistent measures. Die Masern sind eine der ansteckendsten Erkrankungen der Menschheit. Trotz weltweit gesunkener Inzidenz kommt es weiterhin zu Masernausbrüchen mit z. T. hohen Fallzahlen. Epidemiologische Erkenntnisse und die molekulare Surveillance durch Genotypisierung von Masernviren liefern wichtige Hinweise bzgl. der endemischen Verbreitung der Viren. Bereits bei Verdacht auf einen Masernfall sollten sofort Maßnahmen eingeleitet werden.
- Open Access
- 21 May 2014
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 14 (1) , 69
Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools
The Project on a Framework for Rating Evidence in Public Health (PRECEPT) was initiated and is being funded by the European Centre for Disease Prevention and Control (ECDC) to define a methodology for evaluating and grading evidence and strength of recommendations in the field of public health, with emphasis on infectious disease epidemiology, prevention and control. One of the first steps was to review existing quality appraisal tools (QATs) for individual research studies of various designs relevant to this area, using a question-based approach. Through team discussions and expert consultations, we identified 20 relevant types of public health questions, which were grouped into six domains, i.e. characteristics of the pathogen, burden of disease, diagnosis, risk factors, intervention, and implementation of intervention. Previously published systematic reviews were used and supplemented by expert consultation to identify suitable QATs. Finally, a matrix was constructed for matching questions to study designs suitable to address them and respective QATs. Key features of each of the included QATs were then analyzed, in particular in respect to its intended use, types of questions and answers, presence/absence of a quality score, and if a validation was performed. In total we identified 21 QATs and 26 study designs, and matched them. Four QATs were suitable for experimental quantitative study designs, eleven for observational quantitative studies, two for qualitative studies, three for economic studies, one for diagnostic test accuracy studies, and one for animal studies. Included QATs consisted of six to 28 items. Six of the QATs had a summary quality score. Fourteen QATs had undergone at least one validation procedure. The results of this methodological study can be used as an inventory of potentially relevant questions, appropriate study designs and QATs for researchers and authorities engaged with evidence-based decision-making in infectious disease epidemiology, prevention and control.
- 21 May 2014
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 14 (1) , 69
Open AccessEvidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools
The Project on a Framework for Rating Evidence in Public Health (PRECEPT) was initiated and is being funded by the European Centre for Disease Prevention and Control (ECDC) to define a methodology for evaluating and grading evidence and strength of recommendations in the field of public health, with emphasis on infectious disease epidemiology, prevention and control. One of the first steps was to review existing quality appraisal tools (QATs) for individual research studies of various designs relevant to this area, using a question-based approach. Through team discussions and expert consultations, we identified 20 relevant types of public health questions, which were grouped into six domains, i.e. characteristics of the pathogen, burden of disease, diagnosis, risk factors, intervention, and implementation of intervention. Previously published systematic reviews were used and supplemented by expert consultation to identify suitable QATs. Finally, a matrix was constructed for matching questions to study designs suitable to address them and respective QATs. Key features of each of the included QATs were then analyzed, in particular in respect to its intended use, types of questions and answers, presence/absence of a quality score, and if a validation was performed. In total we identified 21 QATs and 26 study designs, and matched them. Four QATs were suitable for experimental quantitative study designs, eleven for observational quantitative studies, two for qualitative studies, three for economic studies, one for diagnostic test accuracy studies, and one for animal studies. Included QATs consisted of six to 28 items. Six of the QATs had a summary quality score. Fourteen QATs had undergone at least one validation procedure. The results of this methodological study can be used as an inventory of potentially relevant questions, appropriate study designs and QATs for researchers and authorities engaged with evidence-based decision-making in infectious disease epidemiology, prevention and control.
- 24 August 2013
- Published by Springer Nature in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
- Vol. 56 (9) , 1231-1237
Hot Spot: Epidemiologie der Masern und Röteln in Deutschland und Europa
- 24 August 2013
- Published by Springer Nature in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
- Vol. 56 (9) , 1231-1237
Hot Spot: Epidemiologie der Masern und Röteln in Deutschland und Europa
- 24 August 2013
- Published by Springer Nature in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
- Vol. 56 (9) , 1293-1296
Quo vadis Germania? Die Nationale Kommission zur Verifizierung der Elimination der Masern und Röteln
- 24 August 2013
- Published by Springer Nature in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
- Vol. 56 (9) , 1293-1296
Quo vadis Germania? Die Nationale Kommission zur Verifizierung der Elimination der Masern und Röteln
- 17 March 2004
- Published by Wiley in Biometrical Journal
- Vol. 46 (S1) , 141
P2.39: Clinical Surveillance of HIV in Germany (ClinSurv HIV)
- 17 March 2004
- Published by Wiley in Biometrical Journal
- Vol. 46 (S1) , 141
P2.39: Clinical Surveillance of HIV in Germany (ClinSurv HIV)